Publications

At AIDA Oncology, we translate complex tumor biology into clinically validated drug response predictors. Our work focuses on transcriptome-based precision oncology across multiple cancer types, with a particular emphasis on breast cancer.

Docetaxel & Paclitaxel

10-12-2025 | San Docetaxel and Paclitaxel Antonnio Breast Cancer Synospium I | SABCS Late-breaking abstract

Evaluation of a 113-gene predictor of benefit from neoadjuvant T-AC treatment in an I-SPY2 cohort

J.H. Niklassen, T. Berg, B. Ejlertsen, B. Hahn, J. Nart, P.B. Jensen, U.H. Buhl, I.K. Buhl

20-10-2025 | 2025 ESMO Annual Meeting I | Abstract

Predicting Taxane Response in Danish Breast Cancer Patients

T.D. Christensen, J. Nart, A.S. Buhl Rasmussen, J.H. Niklassen, B. Hahn, B. Ejlertsen, A.S. Knoop, F.O. Bagger, S.G. Sørensen, U.H. Buhl, I. Kappel Buhl, E. van Boven, P.B. Jensen

20-10-2025 | 2025 ESMO Annual Meeting I | Abstract

A Machine Learning Model to Accurately Predict Taxane Response in Neoadjuvant Breast Cancer

T. Berg, J.H. Niklassen, B. Ejlertsen, B. Hahn, J. Nart, P. Buhl Jensen, U.H. Buhl, I. Kappel Buhl

Epirubicin & Doxorubicin

29-05-2024 | 2024 ASCO Annual Meeting I | Abstract

Predicting epirubicin response in Danish patients with breast cancer.

Buhl, I. K., Nart, J., Papadovasilakis, Z., Sørensen, S., Jensen, P. B., Ejlertsen, B., ... & Tsamardinos, I.

26-05-2019 | 2019 ASCO Annual Meeting I | Abstract

Doxorubicin response prediction in neoadjuvant breast cancer therapy.

Rasmussen, Anna & Christensen, Ib & Knudsen, Steen & Jensen, Peter.

11-08-2018 | Breast Cancer Research and Treatment | Article

Predicting efficacy of epirubicin by a multigene assay in advanced breast cancer within a Danish Breast Cancer Cooperative Group (DBCG) cohort: a retrospective-prospective blinded study.

Buhl, A.S.K., Christensen, T.D., Christensen, I.J. et al.

30-05-2017 | 2017 ASCO Annual Meeting I | Abstract

Retrospective-prospective blinded evaluation predicting efficacy of epirubicin by a multigene assay in advanced breast cancer within a Danish Breast Cancer Cooperative Group (DBCG) cohort.

Rasmussen, Anna & Christensen, Troels & Christensen, Ib & Nelausen, Knud & Balslev, Eva & Knoop, Ann & Brix, Eva & Svensson, Else & Glavicic, Vesna & Luczak, Adam & Langkjer, Sven & Linnet, Soeren & Jakobsen, Erik & Bogovic, Jurij & Ejlertsen, Bent & Rasmussen, Annie & Hansen, Anker & Knudsen, Steen & Nielsen, Dorte & Jensen, Peter.

Breast Cancer

20-04-2019 | Pharmacogenomics | Publication

A drug response predictor to guide treatment for breast cancer.

Buhl, I. K., Jensen, P. B., Kappel Buhl, A. S., & Knudsen, S.